Explore answers to our most commonly asked questions about CBD, our products, and more.
ARA-290, also known as cibinetide in the literature, is a short peptide derived from the tissue-protective region of erythropoietin. It is studied because it appears to engage protective signaling without behaving like erythropoietin in the classic red-blood-cell sense. For site copy, it should be presented as a research peptide only.
Researchers usually investigate ARA-290 in models involving inflammation, tissue protection, and neuropathic or repair-related signaling. A key point is that it is generally discussed as a non-erythropoietic EPO-derived peptide, meaning the research interest is protective signaling rather than stimulation of red blood cell production.
Our agents are here to help you.
